Bormioli Pharma continues its investments to support the growing demand for packaging solutions for both vaccines and, more generally, for the various therapeutic treatments used to fight Covid-19 infections.
The Vasto plant, specialised in the production of rubber stoppers and aluminium seals for containers used for injectable drugs, is one of the industrial sites where the Group plans to undertake significant works to increase production capacity. The current maximum capacity, which amounts to around 100 million closures per year, will soon reach 150 million and will further increase to 200 million in just a few months.
In this news report – click here to watch the video – broadcast on Rai 3’s Abruzzo regional news, Site Manager, Ezio Scifo, comments on recent investments and some of the important collaborations already underway for vaccine packaging.
10.03.2021, Bormioli Pharma
Notícias sobre o material do site é copyright e pertence à empresa ou ao seu fornecedor de terceiros notícia, e todos os direitos reservados. Qualquer usuário que acessa esse material poderá fazê-lo apenas para seu próprio uso pessoal, bem como a utilização desse material é de risco exclusivo do Utilizador. A redistribuição ou exploração comercial de material tal notícia é expressamente proibida. Se tal notícia material é fornecido por um terceiro, cada utilizador concorda em observar e estar vinculado aos termos específicos de utilização aplicáveis a material notícia. Nós não representamos nem endossamos a precisão ou confiabilidade de qualquer informação contida em qualquer notícia ou sites externos referidos na notícia.
Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.